Načítá se...
Real‐world outcomes of advanced melanoma patients not represented in phase III trials
The aim was to provide evidence on systemically treated patients with advanced melanoma not represented in phase III trials to support clinical decision‐making. Analysis were performed on advanced melanoma patients diagnosed between 2014 and 2017 in the Netherlands, treated with immune‐ or targeted...
Uloženo v:
| Vydáno v: | Int J Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7689762/ https://ncbi.nlm.nih.gov/pubmed/32559817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33162 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|